Dr Reddy’s new US drug pipeline is keeping investors’ pulse ticking
Relaunching some of its older drugs in the US is on the cards. This would provide a fillip to the North American biz.The main reason is the swelling pipeline of drug launches in the US
https://www.livemint.com
Livemint: Dr Reddy’s new US drug pipeline is keeping investors’ pulse ticking.